BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/9/2026 8:15:18 AM | Browse: 42 | Download: 84
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 119774
Country United States
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Opinion Review
Article Title Beyond Biomarkers: Prognostic Value of carcinoembryonic antigen and carbohydrate antigen 19-9 in Postoperative Gastric Cancer
Manuscript Source Invited Manuscript
All Author List Arunkumar Krishnan
ORCID
Author(s) ORCID Number
Arunkumar Krishnan http://orcid.org/0000-0002-9452-7377
Funding Agency and Grant Number
Corresponding Author Arunkumar Krishnan, Department of Supportive Oncology, Atrium Health Levine Cancer, Atrium Health Wake Forest Baptist Comprehensive Cancer Center, 1021 Morehead Medical Dr, Charlotte, NC 28204, United States. dr.arunkumar.krishnan@gmail.com
Key Words Gastric cancer; Carcinoembryonic antigen; Carbohydrate antigen 19-9; Biomarkers; Recurrence; Chemotherapy toxicity; Statistical methodology; Survival analysis
Core Tip A recent study by Qi and Wu on CEA and CA19-9 as predictors of gastric cancer recurrence and chemotherapy toxicity is critically evaluated. Although the findings are clinically relevant, several methodological considerations, such as selection bias, temporal ambiguity in biomarker-outcome relationships, insufficient control of confounders, suboptimal survival analysis methods, and limited predictive performance assessment, restrict the clinical generalizability of the findings. There is a need for rigorous multivariable adjustment, proper time-to-event analysis, and validation of clinical utility before these biomarkers can be used to guide individualized postoperative management strategies.
Publish Date 2026-10-09 08:15
Citation

Krishnan A. Beyond Biomarkers: Prognostic Value of carcinoembryonic antigen and carbohydrate antigen 19-9 in Postoperative Gastric Cancer. World J Gastrointest Oncol 2026; 18(10): 119774

URL https://www.wjgnet.com/1948-5204/full/v18/i10/119774.htm
DOI https://doi.org/10.4251/wjgo.119774
Full Article (PDF) WJGO-18-119774-with-cover.pdf